Search research articles
Contact Us
Filters
Showing results (91-100 of 346) with videos related to
Page
of 35
Sort By:
JCO Clinical Cancer Informatics
|
May 2, 2025
Performance of Two-Phase Designs for the Time-to-Event Outcome and a Case Study Assessing the Relapse Risk Associated With B-ALL Subtypes
Wenan Chen, Ti-Cheng Chang, Karen R Rabin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 5, 2002
Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia
Joseph L Wiemels, Brian C Leonard, Yunxia Wang, et al.
Haematologica
|
June 26, 2025
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial
Laura E Hogan, Teena Bhatla, Xinxin Xu, et al.
British Journal of Haematology
|
April 9, 2019
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group
Terzah M Horton, James A Whitlock, Xiaomin Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2008
Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study
Jeffrey E Rubnitz, David Wichlan, Meenakshi Devidas, et al.
Blood Advances
|
August 5, 2025
Prognostic Impact of the PredicT-ALL Classifier in the AALL0434 Trial: A Model Combining NGS, MRD and WBC at Diagnosis
Mathieu Simonin, Nicolas Boissel, Arnaud Petit, et al.
Blood
|
June 7, 2013
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group
Wanda L Salzer, Barbara Asselin, Jeffrey G Supko, et al.
Haematologica
|
November 30, 2023
B-cell acute lymphoblastic leukemia and juvenile xanthogranuloma in a patient with <i>ETV6</i> thrombocytopenia and leukemia predisposition syndrome: novel clinical presentation and perspective
Haley Newman, Suzanne P MacFarland, Garrett M Brodeur, et al.
Journal of Proteomics
|
June 11, 2008
Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients
Susan E Abbatiello, Yuan-Xiang Pan, Mi Zhou, et al.
British Journal of Haematology
|
July 5, 2014
Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia
Smita Dandekar, Eleny Romanos-Sirakis, Faye Pais, et al.
Page
of 35
Search research articles
Search
Showing results (91-100 of 346) with videos related to
Sort By:
Page
of 35
JCO Clinical Cancer Informatics
|
May 2, 2025
Performance of Two-Phase Designs for the Time-to-Event Outcome and a Case Study Assessing the Relapse Risk Associated With B-ALL Subtypes
Wenan Chen, Ti-Cheng Chang, Karen R Rabin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 5, 2002
Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia
Joseph L Wiemels, Brian C Leonard, Yunxia Wang, et al.
Haematologica
|
June 26, 2025
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial
Laura E Hogan, Teena Bhatla, Xinxin Xu, et al.
British Journal of Haematology
|
April 9, 2019
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group
Terzah M Horton, James A Whitlock, Xiaomin Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2008
Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study
Jeffrey E Rubnitz, David Wichlan, Meenakshi Devidas, et al.
Blood Advances
|
August 5, 2025
Prognostic Impact of the PredicT-ALL Classifier in the AALL0434 Trial: A Model Combining NGS, MRD and WBC at Diagnosis
Mathieu Simonin, Nicolas Boissel, Arnaud Petit, et al.
Blood
|
June 7, 2013
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group
Wanda L Salzer, Barbara Asselin, Jeffrey G Supko, et al.
Haematologica
|
November 30, 2023
B-cell acute lymphoblastic leukemia and juvenile xanthogranuloma in a patient with <i>ETV6</i> thrombocytopenia and leukemia predisposition syndrome: novel clinical presentation and perspective
Haley Newman, Suzanne P MacFarland, Garrett M Brodeur, et al.
Journal of Proteomics
|
June 11, 2008
Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients
Susan E Abbatiello, Yuan-Xiang Pan, Mi Zhou, et al.
British Journal of Haematology
|
July 5, 2014
Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia
Smita Dandekar, Eleny Romanos-Sirakis, Faye Pais, et al.
Page
of 35